Circular RNA Expression Profile of Pancreatic Ductal Adenocarcinoma Revealed by Microarray

Background/Aims: Circular RNAs (circRNAs) are a special novel type of a stable, diverse and conserved noncoding RNA in mammalian cells. Particularly in cancer, circRNAs have been reported to be widely involved in the physiological/pathological process of life. However, it is unclear whether circRNAs are specifically involved in pancreatic ductal adenocarcinoma (PDAC). Methods: We investigated the expression profile of circRNAs in six PDAC cancer samples and paired adjacent normal tissues using microarray. A high-throughput circRNA microarray was used to identify dysregulated circular RNAs in six PDAC patients. Bioinformatic analyses were applied to study these differentially expressed circRNAs. Furthermore, quantitative reverse transcription polymerase chain reaction (qRT-PCR) was performed to confirm these results. Results: We revealed and confirmed that a number of circRNAs were dysregulated, which suggests a potential role in pancreatic cancer. Conclusions: this study demonstrates that clusters of circRNAs are aberrantly expressed in PDAC compared with normal samples and provides new potential targets for the future treatment of PDAC and novel insights into PDAC biology.

[1]  Sol Shenker,et al.  Genome-wide analysis of drosophila circular RNAs reveals their structural and sequence properties and age-dependent neural accumulation. , 2014, Cell reports.

[2]  A. Chinnaiyan,et al.  The emergence of lncRNAs in cancer biology. , 2011, Cancer discovery.

[3]  G. Shan,et al.  Exon-intron circular RNAs regulate transcription in the nucleus , 2015, Nature Structural &Molecular Biology.

[4]  Liang Zhou,et al.  MicroRNA-135a Inhibits Cell Proliferation by Targeting Bmi1 in Pancreatic Ductal Adenocarcinoma , 2014, International journal of biological sciences.

[5]  Barbara Sennino,et al.  Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors. , 2012, Cancer discovery.

[6]  R. DePinho,et al.  Genetics and biology of pancreatic ductal adenocarcinoma , 2006, Genes & development.

[7]  A. Yee,et al.  Foxo3 activity promoted by non-coding effects of circular RNA and Foxo3 pseudogene in the inhibition of tumor growth and angiogenesis , 2016, Oncogene.

[8]  P. Pandolfi,et al.  The multilayered complexity of ceRNA crosstalk and competition , 2014, Nature.

[9]  H. Eguchi,et al.  Involvement of microRNA-181b in the gemcitabine resistance of pancreatic cancer cells. , 2013, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[10]  R. Zeillinger,et al.  Correlation of circular RNA abundance with proliferation – exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues , 2015, Scientific Reports.

[11]  A. Zeiher,et al.  Identification and Characterization of Hypoxia-Regulated Endothelial Circular RNA. , 2015, Circulation research.

[12]  Shanshan Zhu,et al.  Circular intronic long noncoding RNAs. , 2013, Molecular cell.

[13]  Haimin Li,et al.  Circular RNA: A new star of noncoding RNAs. , 2015, Cancer letters.

[14]  G. Jin,et al.  MiR-429 Determines Poor Outcome and Inhibits Pancreatic Ductal Adenocarcinoma Growth by Targeting TBK1 , 2015, Cellular Physiology and Biochemistry.

[15]  Li Yang,et al.  Regulation of circRNA biogenesis , 2015, RNA biology.

[16]  Feng Li,et al.  The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva. , 2015, Clinical chemistry.

[17]  Wolfgang Schima,et al.  Pancreatic adenocarcinoma , 2006, European Radiology.

[18]  Manuel Hidalgo,et al.  Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer , 2011, Proceedings of the National Academy of Sciences.

[19]  J. Satoh,et al.  Gene Expression Profile Following Stable Expression of the Cellular Prion Protein , 2004, Cellular and Molecular Neurobiology.

[20]  J. Kjems,et al.  Circular RNA and miR-7 in cancer. , 2013, Cancer research.

[21]  E. Schuman,et al.  Neural circular RNAs are derived from synaptic genes and regulated by development and plasticity , 2015, Nature Neuroscience.

[22]  Haimin Li,et al.  Microarray expression profile of circular RNAs in human pancreatic ductal adenocarcinoma , 2015, Genomics data.

[23]  Sebastian D. Mackowiak,et al.  Circular RNAs are a large class of animal RNAs with regulatory potency , 2013, Nature.

[24]  Julia Salzman,et al.  Cell-Type Specific Features of Circular RNA Expression , 2013, PLoS genetics.

[25]  M. Tempero,et al.  Therapeutic advances in pancreatic cancer. , 2013, Gastroenterology.

[26]  W. Liu,et al.  Long non-coding RNAs expressed in pancreatic ductal adenocarcinoma and lncRNA BC008363 an independent prognostic factor in PDAC. , 2014, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[27]  Yan Li,et al.  Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs , 2016, Nature Communications.

[28]  Prasenjit Dey,et al.  Genetics and biology of pancreatic ductal adenocarcinoma , 2006, Genes & development.

[29]  J. Kjems,et al.  Natural RNA circles function as efficient microRNA sponges , 2013, Nature.

[30]  B. Zhao,et al.  A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223. , 2016, European heart journal.

[31]  Xuefei Shi,et al.  Long non-coding RNAs: a new frontier in the study of human diseases. , 2013, Cancer letters.

[32]  William R. Jeck,et al.  Expression of Linear and Novel Circular Forms of an INK4/ARF-Associated Non-Coding RNA Correlates with Atherosclerosis Risk , 2010, PLoS genetics.

[33]  Petar Glažar,et al.  Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically Expressed. , 2015, Molecular cell.

[34]  Bond-Smith Giles,et al.  Only women with symptoms need to have their breast implants removed, says government , 2012 .

[35]  Yifeng Zhou,et al.  Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway , 2015, Oncotarget.

[36]  Hui Chen,et al.  Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the NF-κB-mediated VEGF signaling pathway. , 2013, Oncology reports.

[37]  Michael K. Slevin,et al.  Circular RNAs are abundant, conserved, and associated with ALU repeats. , 2013, RNA.

[38]  Zhiyong Guo,et al.  Interaction between microRNA-181a and TNFAIP1 regulates pancreatic cancer proliferation and migration , 2015, Tumor Biology.

[39]  D. Jäger,et al.  Improvement of surgical results for pancreatic cancer. , 2013, The Lancet. Oncology.

[40]  Gerald C. Chu,et al.  Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations. , 2014, Cancer discovery.

[41]  François-Michel Boisvert,et al.  Glycogen Synthase Kinase-3 (GSK3) Inhibition Induces Prosurvival Autophagic Signals in Human Pancreatic Cancer Cells* , 2015, The Journal of Biological Chemistry.

[42]  Hitoshi Suzuki,et al.  A View of Pre-mRNA Splicing from RNase R Resistant RNAs , 2014, International journal of molecular sciences.

[43]  C. Croce,et al.  MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. , 2007, JAMA.

[44]  Huajie Cai,et al.  cir-ITCH Plays an Inhibitory Role in Colorectal Cancer by Regulating the Wnt/β-Catenin Pathway , 2015, PloS one.

[45]  Xiaoyan Mo,et al.  Using circular RNA as a novel type of biomarker in the screening of gastric cancer. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[46]  Rui Yang,et al.  Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer , 2015, Tumor Biology.